Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A3CMGM5
Mon, 31.03.2025
APONTIS PHARMA AG
APONTIS PHARMA with significant sales and earnings increase in 2024 financial year – squeeze-out and merger planned
Sales increases significantly to EUR 48.5 million in 2024 financial year (2023: EUR 37.0 million)
Strong increase in Single Pill combination revenues to EUR 34.4 million (2023: EUR 25.6 million)
EBITDA increases by EUR 16.8 mill [ … ]
Wed, 05.03.2025
APONTIS PHARMA AG
Publication of inside information pursuant to Article 17 of the Regulation (EU) No. 596/2014APONTIS PHARMA AG: Zentiva AG submits formal request to carry out a merger squeeze-out of the minority shareholders of APONTIS PHARMA AG – merger agreement planned
Monheim / Rhein, 5 March 2025. Zentiva AG today submitted a formal request to APONTIS PHARMA [ … ]